Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-30

Clinical Trial Update: Quetiapine Versus Haloperidol in the Management of Hyperactive Delirium [Phase 3]

View source ↗

Summary

Phase 3 trial comparing quetiapine to haloperidol for management of hyperactive delirium has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL (HALOPERIDOL LACTATE)
  • Quetiapine (quetiapine)

Snippet

Sponsor: Alexandria University | Conditions: Hyperactive Delirium | Phase 3 | Status: COMPLETED